학술논문
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective
Document Type
Artikel
Author
Source
American journal of cardiovascular drugs : drugs, devices, and other interventions. 24(1):117-127
Subject
Language
English
English
English
ISSN
1179-187X